Checkpoint Therapeutics to Participate in Three September 2020 Virtual Investor Conferences
NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James F. Oliviero, President and Chief Executive Officer, will participate in three virtual investor conferences in September 2020.
Details of the events are as follows:
Webcasts of the presentations will be available on the Events page, located within the Investors section of Checkpoint’s website, https://ir.checkpointtx.com/event-calendar/default.aspx, for approximately 30 days following each presentation.
About Checkpoint Therapeutics
Investor Relations Contact:
Media Relations Contact: